Page 34 - Product Testing News Today

Press release content from Business Wire. The AP news staff was not involved in its creation. Tenax Therapeutics to Present at the H.C. Wainwright Global Life Sciences Virtual Conference March 4, 2021 GMT Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced that management will present a company overview and hold virtual investor meetin...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update Erytech Pharma S.A.March 4, 2021 GMT ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update Lyon (France) and Cambridge, MA (U.S.), March 4, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating ...

SEOUL, South Korea -- South Korea’s central bank says the country’s economy shrank for the first time in 22 years in 2020 as the coronavirus pandemic destroyed service industry jobs

Press release content from Globe Newswire. The AP news staff was not involved in its creation. MDxHealth Reports Financial Year 2020 Results and Provides Outlook for 2021 MDxHealth (R)March 3, 2021 GMT NEWS RELEASE - REGULATED INFORMATION 3 MARCH 2021, 07:00 A.M. CET Conference call with Q&A today at 08:00 CET / 07:00 GMT, details provided below IRVINE, CA, and HERSTAL, BELGIUM – March 3, 2021 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases March 2, 2021 GMT NEW HAVEN, Conn.--(BUSINESS WIRE)--Mar 2, 2021-- Rallybio, a clinical-stage biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, today announced the details ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Health Canada Approves BRUKINSA® (Zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemia March 2, 2021 GMT CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--Mar 2, 2021-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that BRUKINSA ® (zanubrutinib) has been approved...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with ... Santhera Pharmaceuticals Holding AGMarch 3, 2021 GMT Pratteln, Switzerland, March 3, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that the last patient has completed the last visit for the first period of the placebo-controlled pivotal VISION-DMD study with vamorolone in patients with Duchenne muscu...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Foundation Fighting Blindness To Jointly Host Online Continuing Medical Education (CME, COPE) Webinar March 2, 2021 GMT (PRNewsfoto/Foundation Fighting Blindness) COLUMBIA, Md., March 2, 2021 /PRNewswire/ -- The Foundation Fighting Blindness, the world’s leading private funding source for retinal degenerative disease research, will host an online continuing medical education (CME and COPE) course on Mo...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Novan Bolsters Commercialization Expertise with Election of Steven D. Skolsky to Board of Directors Novan, Inc.March 2, 2021 GMT MORRISVILLE, N.C., March 02, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the election of Steven D. Skolsky to its Board of Directors. Mr. Skolsky is a well-established senior executive with over 35 years of experie...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas (Formerly Kalytera Therapeutics) Cites Breakthrough Data by Massachusetts General ... Claritas Pharmaceuticals, Inc.March 2, 2021 GMT SAN FRANCISCO, March 02, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (formerly Kalytera Therapeutics, Inc.) (TSX VENTURE: KLY and OTC: KALTF) (the “Company” or “Claritas”) today announced that compelling data demonstrating that nitric oxide ...